Evaluation of Clinical, Pathological, and Treatment Effects on Prognosis in Non-Metastatic Esophagus Squamous Cell Carcinoma
Open Access
- 27 March 2026
- journal article
- Published by Pera Yayıncılık Hizmetleri in European Journal of Therapeutics
- Vol. 32 (3) , 290-301
Abstract
Objective: This study analyzed demographic, clinical, and pathological features, treatment responses, and survival outcomes in non-metastatic esophageal SCC patients. Methods: A retrospective review of 74 patients was conducted. Performance status was assessed using ECOG, treatment response via RECIST 1.1, and staging via AJCC 7th edition TNM. Results: The male-to-female ratio was 0.95, with a mean age of 50.6. Tumors were mainly distal (58%), and most patients (68.7%) presented at stage 2 (25%) or 3 (43.7%). Surgery was performed in 64.9% (47.3% surgery only, 35.1% CRT only, 17.6% CRT + surgery). Median overall and disease-free survival were 38 and 24 months, respectively. Female gender, middle/lower tumor location, fewer metastatic lymph nodes, and CRT + surgery correlated with better survival (p < 0.05). Conclusion: Surgery was the most common treatment, but CRT + surgery yielded superior survival. Local recurrence was more frequent than distant metastasis. A combined approach is crucial for optimal outcomes.Keywords
This publication has 31 references indexed in Scilit:
- History and evidence for state of the art of lymphadenectomy in esophageal cancer surgeryDiseases of the Esophagus, 2023
- Detection of human papillomavirus in esophageal and gastroesophageal junction tumors: A retrospective study by real-time polymerase chain reaction in an instutional experience from Turkey and review of literaturePathology - Research and Practice, 2016
- Impact of changing US cigarette smoking patterns on incident cancer: risks of 20 smoking-related cancers among the women and men of the NIH-AARP cohortInternational Journal of Epidemiology, 2015
- Discrepancies between ESMO and NCCN breast cancer guidelines: An appraisalThe Breast, 2015
- Radio(chemo)therapy for locally advanced squamous cell carcinoma of the esophagusStrahlentherapie und Onkologie, 2014
- Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysisThe Lancet Oncology, 2011
- Postoperative Radiotherapy Improved Survival of Poor Prognostic Squamous Cell Carcinoma EsophagusThe Annals of Thoracic Surgery, 2010
- Esophageal cancer: Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2010
- Staging of esophageal carcinoma: Length of tumor and number of involved regional lymph nodes. Are these independent prognostic factors?Journal of Surgical Oncology, 2006
- Management and prognosis of esophageal cancers: Has progress been made?European Journal of Cancer, 2006